Lyell Immunopharma (LYEL) Assets (2020 - 2026)
Lyell Immunopharma (LYEL) reported Assets of $311.15 million for Q2 2026, down 19.3% from $385.45 million a year earlier and down 11.3% from the prior quarter.
Powered by 
Analysis
Lyell Immunopharma (LYEL) Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, Lyell Immunopharma posted Assets of $340.05 million, down 30.7% from FY2024.
- Assets has declined for four consecutive years, with a five-year compound annual growth rate of -17.8% (FY2020 to FY2025).
- By year, Assets came in at $490.86 million in FY2024 (-34.6%), $750.03 million in FY2023 (-20.0%), $937.56 million in FY2022 (-16.8%) and $1.13 billion in FY2021 (+24.1%).
- The Q2 2026 figure ranks as the lowest quarterly Assets in data going back to Q4 2020.
- Year over year, Assets has now declined in each of the last 17 quarters, with an average decline of 29.8% over the last eight quarters.
- The high point for year-over-year Assets in five years was Q4 2021 (growth of 24.1%); the low point was Q2 2025 (a decline of 41.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $350.63 million (Q1 2026), $340.05 million (Q4 2025) and $407.97 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Lyell Immunopharma | 227.89 Mn | 227.89 Mn | - | 311.15 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 311.15 Mn |
| Mar 31, 2026 | 350.63 Mn |
| Dec 31, 2025 | 340.05 Mn |
| Sep 30, 2025 | 407.97 Mn |
| Jun 30, 2025 | 385.45 Mn |
| Mar 31, 2025 | 429.80 Mn |
| Dec 31, 2024 | 490.86 Mn |
| Sep 30, 2024 | 619.22 Mn |
| Jun 30, 2024 | 654.14 Mn |
| Mar 31, 2024 | 694.22 Mn |
| Dec 31, 2023 | 750.03 Mn |
| Sep 30, 2023 | 794.99 Mn |
| Jun 30, 2023 | 835.35 Mn |
| Mar 31, 2023 | 880.45 Mn |
| Dec 31, 2022 | 937.56 Mn |
| Sep 30, 2022 | 977.27 Mn |
| Jun 30, 2022 | 1.02 Bn |
| Mar 31, 2022 | 1.07 Bn |
| Dec 31, 2021 | 1.13 Bn |
| Sep 30, 2021 | 1.20 Bn |
API Access
Lyell Immunopharma Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=LYEL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "LYEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=LYEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();